Gavin W Roddy
Overview
Explore the profile of Gavin W Roddy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Becerra C, Funk R, Kohli D, Hodge D, Roddy G
BMC Ophthalmol
. 2025 Feb;
25(1):73.
PMID: 39934714
Background: Limited population-based data as well as proposed mechanisms of retinal ganglion cell (RGC) loss suggest autoimmune disease may be a risk factor for glaucoma, the leading cause of irreversible...
2.
Acott T, Fautsch M, Mao W, Ethier C, Huang A, Kelley M, et al.
Invest Ophthalmol Vis Sci
. 2024 Dec;
65(14):32.
PMID: 39693082
Intraocular pressure (IOP) elevation is the primary risk factor and currently the main treatable factor for progression of glaucomatous optic neuropathy. In addition to direct clinical and living animal in...
3.
Roddy G, Kohli D, Niknam P, Omer M, Chowdhury U, Anderson K, et al.
Ophthalmol Sci
. 2024 Sep;
5(1):100590.
PMID: 39328825
Purpose: To investigate subconjunctival administration of a single-stranded, adeno-associated virus, serotype 2, engineered to express stanniocalcin-1 with a FLAG tag (ssAAV2-STC-1-FLAG) as a novel sustained (IOP) lowering agent with a...
4.
Kaplan T, Sit A, Patel S, Roddy G
J Glaucoma
. 2024 Aug;
33(8):e64-e75.
PMID: 39141409
Intraocular pressure is currently the only known reliable, modifiable risk factor for the development and progression of glaucoma. Other risk factors for glaucoma include increasing age, myopia, decreased central corneal...
5.
Tailor P, Xu T, Fortes B, Iezzi R, Olsen T, Starr M, et al.
Mayo Clin Proc Digit Health
. 2024 Apr;
2(1):119-128.
PMID: 38577703
Objective: To determine the appropriateness of ophthalmology recommendations from an online chat-based artificial intelligence model to ophthalmology questions. Patients And Methods: Cross-sectional qualitative study from April 1, 2023, to April...
6.
Cameron N, Nayman T, Patel S, Roddy G
Am J Ophthalmol Case Rep
. 2024 Feb;
34:102003.
PMID: 38384737
Purpose: Trabeculectomy surgery is a commonly performed procedure for treatment of glaucoma. While the goal is to lower intraocular pressure, over-filtration may cause hypotony with ocular structural changes and vision...
7.
Liu A, Lyons L, Khanna C, Roddy G, Hodge D, Sit A
J Glaucoma
. 2023 Dec;
33(5):370-374.
PMID: 38129939
Prcis: Damage to disposable selective laser trabeculoplasty (SLT) lenses correlated with the amount of total laser energy. Furthermore, greater lens damage was associated with diminished patient treatment response. Purpose: Disposable...
8.
Kaplan T, Hammer J, Kohli D, Pacheco J, Hodge D, Khanna C, et al.
J Glaucoma
. 2023 Jul;
32(9):762-768.
PMID: 37406302
Prcis: When comparing patients on systemic immunosuppressive therapy to those without, there was no difference in intraocular pressure (IOP) early after SLT; however, at 1 year following SLT, IOP was...
9.
Kohli D, Wu K, White L, Hodge D, Chen J, Roddy G
BMJ Open Ophthalmol
. 2022 Nov;
7(1).
PMID: 36437528
Purpose: To determine whether metabolic syndrome (MetS) is a risk factor for various forms of optic neuropathy including non-arteritic anterior ischaemic optic neuropathy (NAION). Methods: This population-based analysis identified patients...
10.